Similar articles

• Treatment of chronic hepatitis C with amantadine hydrochloride in patients who had not responded to previous treatment with interferon-alpha and/or ribavirin.

  Di Martino V, Boudjema H, Delacour T, Cazier A, Caron C, Coutarel P, Dumouchel P, Cadranel JF. Di Martino V, et al. Clin Infect Dis. 2001 Mar 1;32(5):830-1. doi: 10.1086/319220. Epub 2001 Feb 28. Clin Infect Dis. 2001. PMID: 11229855 Clinical Trial.
• Amantadine: a different approach.

  Torre F, Picciotto A. Torre F, et al. J Hepatol. 2002 May;36(5):705. doi: 10.1016/s0168-8278(02)00030-2. J Hepatol. 2002. PMID: 11983458 No abstract available.
• Amantadine monotherapy of chronic hepatitis C patients infected with genotype lb.

  Senturk H, Mert A, Akdogan M, Tabak F, Basaran G, Turkoglu S, Ozbay G, Badur S. Senturk H, et al. Scand J Infect Dis. 2000;32(5):575-6. doi: 10.1080/003655400458965. Scand J Infect Dis. 2000. PMID: 11055673
• Amantadine for chronic hepatitis c: a magic bullet or yet another dead duck?

  Craxi A, Lo Lacono O. Craxi A, et al. J Hepatol. 2001 Oct;35(4):527-30. doi: 10.1016/s0168-8278(01)00184-2. J Hepatol. 2001. PMID: 11682040 Free PMC article. Review. No abstract available.
• Role of amantadine and other adjuvant therapies in the treatment of hepatitis C.

  Brillanti S. Brillanti S. Semin Liver Dis. 2004;24 Suppl 2:89-95. doi: 10.1055/s-2004-832933. Semin Liver Dis. 2004. PMID: 15346251 Review.